Enjoy Free Shipping on Orders above $220
Rybelsus 14 mg is a prescription oral medication for the treatment of Type 2 Diabetes in adults whose blood sugar is not manageable by diet and exercise alone. It is manufactured by Novo Nordisk, a WHO-GMP-certified, globally trusted pharmaceutical company.
Its active salt is Semaglutide, belonging to the Glucagon-like Peptide Receptor Agonist (GLP-1 RA) medication class. It works by stimulating insulin release when blood sugar is high, thereby lowering liver glucose output and slowing gastric emptying. This helps reduce blood glucose and minimize appetite, thus maintaining blood sugar levels and weight.
Rybelsus is the first GLP-1 receptor agonist available in an oral tablet form. Taken once daily by mouth, this prescription-based Semaglutide tablet for Type 2 Diabetes eliminates the need for hospital or self-administered injections like Ozempic or Wegovy. Rybelsus is not for use in Type 1 Diabetes or Diabetic Ketoacidosis. It should not be given to children or patients with a known allergy to GLP-1 receptor agonists.
With mild nausea, upset stomach and constipation as the most common side effects, the proven benefits of Rybelsus in Diabetes and weight management outweigh the temporary discomfort for most patients. However, those with a history of Multiple Endocrine Neoplasia syndrome Type 2 (MEN 2) and Medullary Thyroid Carcinoma (MTC) should altogether avoid it.
Semaglutide works by mimicking GLP-1 hormones, increasing insulin release when blood sugar is high. This results in maintaining optimum levels in Type-2 Diabetes patients.
Moreover, it helps with:
Thus, Rybelsus 14 mg tablets not only control blood glucose but also support weight management and protect the heart, helping patients live healthier and more active lives.
Follow your doctor’s advice for maximum blood sugar and weight loss results. Typically, patients are directed to:
Continue your diet and Diabetes exercise plan alongside medication for the best possible and sustainable outcomes.
Rybelsus tablets are available in multiple strengths of 3 mg, 7 mg, and 14 mg. However, these formulations are not interchangeable by weight.
Currently, it is the only oral form available. Other substitutes include Ozempic and Wegovy, both injectable forms of Semaglutide.
| $89.20/10 tablets | |
| $99.00/10 tablets |
Semaglutide may cause some mild and temporary side effects, such as:
In rare cases, it may cause Pancreatitis, complications of Diabetic Retinopathy, or Kidney Injury from dehydration. Consult a medical professional if side effects become severe or persistent.
Liver disease
No dosage adjustment for Rybelsus is necessary in patients with mild to moderate hepatic impairment. Having said that, caution and routine monitoring are recommended.
Kidney impairment
Semaglutide is generally safe in patients with mild to moderate kidney impairment without needing dose adjustment. However, kidney function should be monitored closely, especially if dehydration occurs. Keep rehydrating with electrolytes, especially during the beginning stages of this oral treatment.
Pregnant and breastfeeding women
It is not recommended during pregnancy and should not be used while breastfeeding due to limited safety data.
Avoid
Limit consumption of alcohol, as it may worsen the risk of Hypoglycemia. Avoid high-salt, high-sugar and fatty foods for optimal results.
It can interact with other diabetes medicines, thyroid hormones, and oral drugs that are dependent on quick stomach absorption.
No, 14 mg is the maximum recommended and available dose of Rybelsus. Higher doses do not improve results but increase side effects such as severe nausea or low blood sugar. Always take Semaglutide dosage as prescribed by your Endocrinologist.
Based on animal studies, Rybelsus carries a boxed warning about the possible risk of Thyroid C-cell Tumors. This means it should not be used in patients with a personal or family history of MTC or MEN 2.
Do not eat or drink anything except water within 30 minutes of taking Rybelsus. Avoid alcohol, high-fat and sugary foods, which may slow its absorption and worsen side effects.
No, you should not take Rybelsus at night. For optimal absorption, it must be taken on an empty stomach at least 30 minutes before your first meal, beverage, or medicine.
Due to slowed stomach emptying, Rybelsus may interact with Insulin, Sulfonylureas, Levothyroxine, and certain oral medicines. So it is best to avoid these. Always disclose all medications and supplements you are taking to your doctor to avoid possible drug interactions.
No, you should not refrigerate Rybelsus. Store it in a dry place at room temperature between 68°F and 77°F. Keep it in the original packaging and out of reach of children and pets.
Not necessarily. Metformin is usually the first-line treatment for Type 2 Diabetes due to its long-term safety and cost-effectiveness. Whereas, Rybelsus is prescribed when Metformin is insufficient or not tolerated by the patient. Still, it can’t technically be termed a substitute.
Yes, Metformin and Rybelsus can be safely taken together. It is a common and effective combination for blood sugar control in Type 2 Diabetes. Studies show this combination yields superior blood glucose control compared to either medication alone, and is standard when monotherapy fails to reach glycemic targets.
No, they are not the same. Jardiance (Empagliflozin) is an SGLT2 (Sodium-glucose cotransporter 2) inhibitor that lowers glucose by increasing urinary excretion, while the latter is a GLP-1 receptor agonist. Both lower A1C and offer heart benefits, but differ in mechanism and dosing.
Yes, Wegovy (Semaglutide injectable) is FDA-approved for weight management and is more potent for weight loss than oral Rybelsus due to its higher dosing and the body’s reactions. In trials, Wegovy 2.4mg weekly yielded 15% average body weight loss vs. 5-7% for the Rybelsus 14mg dose.
It depends on your individual requirements and ease of use. In head-to-head studies, Ozempic (injectable Semaglutide) produces greater A1C and body weight reductions than Rybelsus (oral Semaglutide). However, your doctor will prescribe one of these based on your condition, form of administration and targeted results.
No, Rybelsus is not approved for non-diabetic weight loss or use in people without Type 2 Diabetes. However, you can take it if prescribed off-label as an Obesity treatment medication. It is usually recommended in combination with lifestyle changes in adults with a BMI (Body Mass Index) of 27 or higher.
Yes, Rybelsus is clinically proven to promote weight loss. In clinical trials, adults with Type 2 Diabetes lost, on average, 2 to 4 kg (4.4 to 8.8 pounds) over six months on Rybelsus 14mg and up to 4.7 kg (10.3 pounds) in a year, especially when paired with a good diet and consistent exercise.
You can begin losing weight on Rybelsus within weeks, but it becomes more noticeable after 3-6 months of consistent use. In clinical studies, maximum sustained weight loss was usually seen by 12 months.
On average, the cost of a monthly stock of Rybelsus (30 tablets) in the USA is $800-$1,000, in the UK £100-£200. Assistance programs and insurance may help reduce costs for eligible patients. You can also buy Rybelsus 3 mg, 7 mg or 14 mg online at affordable prices from our Indian pharmacy, Cheap Medicine Shop.
